Humana
Louisville insurer and #2 Medicare Advantage player with its own clinics and pharmacy arm.
Humana keeps gaining Medicare Advantage members while its star ratings collapse and earnings shrink until at least 2028.
Humana sells health insurance, especially to older adults on Medicare, and operates through government-approved plans and state licenses that competitors like UnitedHealth cannot easily replicate or bypass. The company is losing billions in bonus payments from the government because its health plan ratings dropped, cutting profits in half through 2026, though management expects to recover by 2028. Whether that recovery happens depends on three things: a court ruling on the bonus payments, the government's pricing decision for 2027, and Humana's earnings report this spring, which together will show if the company is truly bouncing back or sinking deeper.
Outcome of Humana's pending star-ratings litigation appeal. An adverse ruling would add to the $1-3B bonus-payment loss and delay 2028 recovery.
2027 CMS star-ratings release in October 2026. A third straight year of decline would suggest a structural, not cyclical, problem.
- FY2025 revenue $129.664B, up 10.1% YoY
- ~7M MA members, 20% national share, #2 spot
- Only 20% of MA members in 4+ star plans, down from 94%
- Star-ratings litigation loss could deepen $1-3B bonus payment losses if appeal fails.
- CMS 2027 MA rate proposal came in soft, pressuring 2027 bids and margins further.
- Adjusted EPS guided down ~50% YoY for 2026, margin recovery not targeted until 2028.
- Industry-wide DOJ/Inspector General scrutiny over MA risk-adjustment upcoding practices.
- Optum/UnitedHealth network access dispute in Washington state as of December 2025.
| Rival | Direction | Evidence |
|---|---|---|
| UnitedHealth Group/UnitedHealthcare | contesting | UnitedHealth holds 26% MA share vs Humana's 20%, but Humana gained ~1M+ members in 2026 while UnitedHealth lost members |
| CVS Health/Aetna | gaining on | CVS/Aetna holds ~12% MA share (~4M enrollees) but was shedding members as of June 2026 while Humana grew |
| Elevance Health | gaining on | Elevance at ~5% MA share (~1.9M enrollees) lost members in 2026 amid Humana's anti-cyclical growth |
| Devoted Health, Clover Health, Alignment Health, SCAN Group | contesting | Insurtech challengers cited as gaining MA share as of June 18, 2026 report |
| CMS (regulator, not competitor but structural threat) | losing to | Lost second star-ratings lawsuit Oct 14, 2025; $1-3B bonus payment risk on appeal |
- Is Humana profitable in 2026?
- Yes but margins are collapsing. Humana affirmed FY2026 adjusted EPS guidance of at least $9.00, down roughly 50% from 2025's $17.14, per its April 29, 2026 first quarter results, driven by star-ratings losses and CMS bonus payment cuts.
- Could AI replace Humana's workforce?
- Unlikely to replace the core insurer, though call-center roles are exposed. Humana's Agent Assist tool, built with Google Cloud Vertex AI and Gemini, launched February 2026 to support 20,000 member advocates handling about 80 million calls per year, automating tasks rather than eliminating the underwriting business.
- Who is Humana's biggest competitor?
- UnitedHealth Group/UnitedHealthcare, which holds 26% of the national Medicare Advantage market versus Humana's 20% as of July 2026, per KFF. Notably, Humana added about 1 to 1.3 million net new MA members for 2026 while UnitedHealth lost members.
- Why did Humana's stock and earnings guidance drop in 2026?
- Humana lost a second Medicare Advantage star-ratings lawsuit against CMS on October 14, 2025, putting $1 billion to $3 billion of 2026 bonus payments at risk; only 20% of its MA members were in 4+ star plans for the 2026 bonus year, down from 94% in 2024.
- Who owns Humana?
- Humana Inc. is publicly traded on the NYSE under ticker HUM with no parent company, holding a market capitalization of approximately $48.0 billion as of July 20, 2026, according to gurufocus.com.
- When will Humana's margins recover?
- CEO Jim Rechtin, in office since July 2024, has targeted a 'stable, compelling MA margin' by 2028, per the Q4 2025 earnings call on February 11, 2026, framing 2026-2027 as a multi-year turnaround trough tied to star ratings and CMS rate cuts.
- 2026-07-29Humana Q2 2026 earnings release scheduled
- 2026-07-20Market cap approximately $48.0 billion, shares near $399.51
- 2026-07-13FY2026 revenue guidance affirmed at least $160 billion
- 2026-07-01KFF reports Humana at 20% national MA share, ~7M enrollees, #2 to UnitedHealth
- 2026-05-26Completed $83M CenterWell Pharmacy distribution center in Orlando, FL
- 2026-04-29Q1 2026 results; FY2026 GAAP EPS guidance cut to at least $8.36
- 2026-02-24Reported ~1.03-1.3M net new MA members for 2026, anti-cyclical to peers
- 2026-02-11Q4 2025 earnings call; CEO Rechtin frames 2028 margin recovery target
- 2026-02-02Launched Agent Assist agentic AI tool with Google Cloud Vertex AI/Gemini
- 2025-10-14Lost second CMS star-ratings lawsuit; $1-3B 2026 bonus payment risk
- gurufocus.com (2026-07-20)
- Humana 10-K (2026-02-19)
- Humana Reports First Quarter 2026 Financial Results (2026-04-29)
- Humana (HUM) Earnings Report Q1 2026 (2026-07-13)
- Medicare Advantage in 2026: Enrollment Update (2026-07-01)
- Medicare Advantage growth decelerates (2026-02-24)
- Humana Reports Fourth Quarter 2025 Financial Results (2026-02-10)
- Humana Number of Employees 2026 (2026-06-29)
- Humana Redefines the Member Experience (2026-02-02)
- Humana loses Medicare Advantage stars lawsuit for a second time (2025-10-14)
- Humana to appeal loss in MA star ratings lawsuit (2025-11-25)
- Humana loses challenge to 2025 Medicare Advantage ratings (2025-10-14)